Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Japan
Japan
Sanofi's Xenpozyme gets approval in Japan for rare genetic disease
Seeking Alpha
Mon, 03/28/22 - 10:30 am
Sanofi
Xenpozyme
Japan
ASMD
Shionogi's COVID-19 vaccine matches Pfizer's Comirnaty in booster trial
Fierce Biotech
Fri, 03/4/22 - 09:46 am
Shionogi
vaccines
COVID-19
Japan
Pfizer
Shionogi files for approval of oral COVID-19 antiviral in Japan, brushing off missed clinical endpoint in race to market
Fierce Biotech
Mon, 02/28/22 - 11:19 am
Shionogi
Japan
antivirals
COVID-19
Amgen Snags Another Approval for This Promising Cancer Drug
Motley Fool
Wed, 02/16/22 - 10:48 am
Amgen
Japan
Lumakras
non-small cell lung cancer
advanced non-small cell lung cancer
Daiichi makes play for share of Japan’s COVID booster market
Pharmaforum
Mon, 01/31/22 - 10:49 am
Daiichi Sankyo
COVID-19
vaccines
MRNA
Japan
DS-5670
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators
Fierce Pharma
Wed, 12/22/21 - 11:06 am
Biogen
Eisai
Aduhelm
Japan
Alzheimer's disease
Merck inks yet another $1B-plus supply deal for COVID pill, this time with Japan
Fierce Pharma
Wed, 11/10/21 - 09:32 pm
Merck
COVID-19
molnupiravir
Japan
Takeda bags Japanese approval for Crohn’s cell therapy Alofisel
Pharmaforum
Mon, 09/27/21 - 10:49 am
Takeda
Alofisel
cell therapy
Crohn's Disease
Japan
Takeda eyes vaccine business growth amid COVID-19 partnerships and dengue progress, CEO says
Fierce Pharma
Tue, 09/14/21 - 10:45 pm
Takeda
vaccines
Moderna Therapeutics
Novavax
COVID-19
Japan
Merck Investors Have Reason to Cheer This Label Expansion
Motley Fool
Thu, 09/9/21 - 10:54 am
Merck
Keytruda
Japan
triple negative breast cancer
Takeda fleshes out CNS pact with peptide drugmaker, setting aside $3.5B in future milestones
Endpoints
Tue, 07/27/21 - 10:31 am
Takeda
CNS
peptides
Japan
PeptiDream
Fresh off $598M deal with Novo Nordisk, a Japanese stem cell company is on its way to the clinic with a different approach to treating heart failure
Endpoints
Fri, 06/11/21 - 10:56 am
heart failure
Heartseed
Japan
Novo Nordisk
stem cells
Japan authorizes AstraZeneca and Moderna’s Covid-19 vaccines
Pharmaceutical Business Review
Mon, 05/24/21 - 10:51 am
Japan
COVID-19
vaccines
AstraZeneca
Moderna Therapeutics
Japan approves two more COVID vaccines as fourth infection wave hits
Pharmaforum
Fri, 05/21/21 - 10:45 am
Japan
COVID-19
vaccines
AstraZeneca
Moderna Therapeutics
This Under-the-Radar Pharma Company's Recent Success Is Just the Beginning
Motley Fool
Sun, 05/9/21 - 10:57 pm
Catalyst Pharmaceuticals
Firdapse
Japan
J&J Vision and Menicon Tackle Myopia with Contact Lens Collaboration
Medical Devices and Diagnostics Industry
Wed, 04/7/21 - 07:18 pm
JNJ
Menicon
myopia
contact lens
Japan
devices
Medtech
Daiichi takes mRNA COVID-19 vaccine into clinic as Japanese R&D belatedly fires up
Fierce Biotech
Mon, 03/22/21 - 10:37 am
Daiichi Sankyo
MRNA
COVID-19
vaccines
Japan
Merck and AstraZeneca's Cancer Drug Wins 3 New Approvals in Japan
Motley Fool
Tue, 12/29/20 - 10:57 am
Merck
AstraZeneca
Japan
ovarian cancer
prostate cancer
pancreatic cancer
Lynparza
Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up
Endpoints
Tue, 12/15/20 - 08:22 pm
Takeda
gene editing
Japan
AnGes
EmendoBio
Astellas, FibroGen get approval in Japan for Evrenzo to treat anaemia of CKD in adult patients not on dialysis
Pharmaceutical Business Review
Sun, 11/29/20 - 02:10 pm
Astellas
FibroGen
Japan
Evrenzo
chronic kidney disease
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »